ABBVIE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 154.2 EUR | -1.46% |
|
+0.74% | +10.08% |
| Jul. 12 | AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis | MT |
| Jul. 12 | AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis | DJ |
Quotes 5-day view
Delayed Quote Xetra| 2024-07-10 | 2024-07-11 | 2024-07-12 | 2024-07-15 | |
|---|---|---|---|---|
| Last | 154.88 € | 156.24 € | 156.5 € | 154.22 € |
| Volume | 645 | 124 | 397 | 781 |
| Change | -0.08% | +0.88% | +0.17% | -1.46% |
| Opening | 155.08 | 155.36 | 156.66 | 155.62 |
| High | 156.32 | 156.24 | 157.90 | 156.06 |
| Low | 153.58 | 154.50 | 155.22 | 154.22 |
Performance
| 1 day | -1.46% | ||
| 1 week | +0.74% | ||
| Current month | -2.71% | ||
| 1 month | -2.17% | ||
| 3 months | +1.26% | ||
| 6 months | +3.71% | ||
| Current year | +10.08% | ||
| 1 year | +28.09% | ||
| 3 years | +56.19% | ||
| 5 years | +90.51% |
Volumes
marketsDaily volume
781
Estimated daily volume
781
Avg. Volume 20 sessions
492
Daily volume ratio
1.59
Avg. Volume 20 sessions
75 876.24
Avg. Volume 20 sessions USD
82 676.27
Record volume 1
360 529
Record volume 2
179 781
Record volume 3
86 235
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
300 691 965 748
Capitalization (USD)
300 691 965 748
Net sales (USD)
54 318 000 000
Number of employees
50 000
Sales / Employee (USD)
1 086 360
Free-Float
96.38 %
Free-Float capitalization (EUR)
327 286 909 454
Free-Float capitalization (USD)
300 351 524 093
Average Daily Capital Traded
0%
Highs and lows
1 week
152.34
157.90
1 month
151.44161.72
Current year
140.20168.92
1 year
119.20168.92
3 years
90.00168.92
5 years
57.80168.92
10 years
41.00168.92
Indicators
Moving average 5 days
155.23
Moving average 20 days
157.36
Moving average 50 days
152.84
Moving average 100 days
156.72
Price spread / (MMA5)
+0.66%
Price spread / (MMA20)
+2.03%
Price spread / (MMA50)
-0.89%
Price spread / (MMA100)
+1.62%
STIM
RSI 9 days
53.04
RSI 14 days
52.66
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.46% | +0.74% | +10.08% | +28.09% | 301B | ||
| +0.22% | +3.92% | +63.05% | +111.47% | 854B | ||
| -0.71% | -0.07% | +39.42% | +83.05% | 636B | ||
| -0.43% | +1.88% | -4.78% | -6.65% | 361B | ||
| +0.28% | +1.32% | +17.52% | +19.36% | 324B | ||
| -1.27% | +0.40% | +14.19% | +17.24% | 247B | ||
| +1.53% | +6.33% | +5.81% | -4.61% | 230B | ||
| -0.96% | +2.58% | +16.77% | +16.64% | 228B | ||
| -0.21% | +6.20% | +14.63% | +45.17% | 177B | ||
| +0.62% | +3.74% | +1.08% | -19.88% | 164B | ||
| -2.09% | +1.64% | +2.97% | -1.36% | 129B | ||
| +1.21% | +6.18% | -12.59% | -8.27% | 87.16B | ||
| -0.77% | +1.24% | -21.75% | -35.18% | 82.02B | ||
| -0.66% | +4.12% | +54.62% | +52.34% | 72.4B | ||
| -1.10% | +1.35% | +17.63% | +62.29% | 65.49B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| Average | -0.39% | +3.00% | +14.58% | +23.98% | ||
| Weighted average by Cap. | -0.31% | +2.76% | +25.25% | +44.51% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
735ca614310af36f7c20affd61b.egEAiz9Oxp1b5a_k9ri8Eq6jR_BT2uhwQFpHGTcVpoA.DGNv5Ew5i_IZp-62h4yNIsSSDKkAqIA5eBEQfw84_rIwRnbybz-qyW6Nlw
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 11:35:46 am | 154.2 | 26 | 781 |
| 11:26:35 am | 154.4 | 2 | 755 |
| 11:26:35 am | 154.3 | 50 | 753 |
| 10:37:05 am | 154.8 | 2 | 703 |
| 10:26:33 am | 155.3 | 2 | 701 |
| 09:53:48 am | 155.8 | 3 | 699 |
| 09:39:01 am | 155.1 | 18 | 696 |
| 09:31:37 am | 154.4 | 200 | 678 |
| 09:31:37 am | 154.6 | 8 | 478 |
| 09:06:14 am | 154.9 | 7 | 470 |
Monthly variations
Annual change
| 2024 | +10.08% | ||
| 2023 | -7.88% | ||
| 2022 | +27.48% | ||
| 2021 | +39.42% | ||
| 2020 | +9.42% | ||
| 2019 | -3.40% | ||
| 2018 | -0.83% | ||
| 2017 | +35.78% | ||
| 2016 | +11.81% | ||
| 2015 | -0.85% | ||
| 2014 | +21.14% |
- Stock Market
- Equities
- ABBV Stock
- 4AB Stock
- Quotes AbbVie Inc.
